Aeglea BioTherapeutics Market Cap 2011-2024 | AGLE

As of December 03, 2024 Aeglea BioTherapeutics has a market cap of $ 1.01 B

The capitalization of a company is the product of the price of a share for the number of shares issued and listed. Market capitalization (Market Cap) is an important market indicator of the value of shares and the value of companies in general.^[1]

Typically, market capitalization is divided into several categories: large cap (over $10 billion), mid cap ($2-10 billion), and small cap (less than $2 billion). Companies with large market capitalization are considered more stable and liquid, while companies with small market capitalization may have greater growth potential but also higher levels of risk.

Market Cap can also be used to compare different companies within an industry or market. For example, comparing the market capitalization of two companies can help determine which one is more valuable or promising for investment.

Annual Market Cap Aeglea BioTherapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
82.8 M	1.35 M	12.5 M	420 M	226 M	187 M	104 M	39.3 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
420 M	1.35 M	134 M

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.